Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 11Prostatic Neoplasms 9Uterine Neoplasms 2Hyperthermia 2Endometrial Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Clear Cell Adenocarcinoma 1Directly Observed Therapy 1Cervical Adenocarcinoma 1Carcinoma, Renal Cell 1Adenocarcinoma 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 34Cisplatin 25Blood Specimen Collection 25durvalumab 17Paclitaxel 16osimertinib 15Radiotherapy 15Radiosurgery 15Bevacizumab 15Gemcitabine 14atezolizumab 13Nivolumab 13Biopsy 13Drug Therapy 12Standard of Care 10Practice Guidelines as Topic 10Immunoglobulin G 10Docetaxel 10130-nm albumin-bound paclitaxel 10X-Rays 9Taxes 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Brachytherapy × Clear all
NCT03290534 2025-04-04

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

CivaTech Oncology

Phase 2 Recruiting
40 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡